exel stock price target

MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Enjoy free access to the POWR Ratings for all stocks and ETFs on the quote pages. There’s a big reason why this company’s shares are on the move, You don’t want to miss out on a chance to be a part of this innovative company who is becoming a powerful weapon on the fight against Covid-19. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Receive a free world-class investing education from MarketBeat. The current projected Exelixis target price consensus is 30.6 with 10 analyst opinions. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 The current analyst and expert consensus on Exelixis is Buy, with 0 strong sell and 7 strong buy opinions. On average, analysts give Exelixis, Inc. a Strong Buy rating. Oppenheimer increased their target price on shares of Exelixis from $33.00 to $37.00 and gave the stock an outperform rating in … Rapidly expanding Bay Area cannabis providers like Juva Life (OTC: JUVAF) are aiming to cash in.document.write(''); This plant based stock has investor interest surging after completing $11.5m financing. Trade Grade Based on 9 analysts offering 12 month price targets for Exelixis in the last 3 months. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock. View which stocks are hot on social media with MarketBeat's trending stocks report. Please log in to your account or sign up in order to add this asset to your watchlist. What price target have analysts set for EXEL? The dark blue line represents the company's actual price. Their average twelve-month price target is $31.78, suggesting a possible upside of 33.9%. Export data to Excel for your own analysis. 10 equities research analysts have issued 12 month price objectives for Exelixis' stock. Make investment decisions regarding EXEL using the data that counts. Exelixis, Inc. (EXEL) estimates and forecasts Fundamental company data provided by Morningstar and Zacks Investment Research. Learn more. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . Friday, July 13, 2018. In recent trading, shares of Exelixis Inc (Symbol: EXEL) have crossed above the average analyst 12-month target price of $24.30, changing hands for $24.56/share.  Peer Grade Want to see which stocks are moving? The stock has traded between $20.48 and $20.83 so far today. The Company is focused on discovery, development and commercialization of new medicines to manage care and outcomes for people with cancer. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. EXEL has a less variance in analysts' estimates than 27.37% of Business Services stocks. Do Not Sell My Information. Their average twelve-month price target is $31.78, predicting that the stock has a possible upside of 42.50%. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. Start Your Risk-Free Trial Subscription Here, Tufin Software (NYSE: TUFN) Stock is Ready for Multiple Expansion. Try POWR Ratings for free. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. There are currently 3 hold ratings and 7 buy ratings for the stock, resulting in a consensus rating of "Buy.". EXEL has a greater upside potential (average analyst target price relative to current price) than 78.93% of all US stocks. 05:33 PM ET. These 17 stocks may be tasty for bottom-feeding investors MarketWatch. Exelixis, Inc. is a biopharmaceutical company. EXEL has been the topic of several analyst reports. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. See what's happening in the market right now with MarketBeat's real-time news feed. Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors. EXEL has a lower change in bullishness amongst analysts than nearly 100% of all US stocks. Now people are pouring into cryptos like we haven’t seen in years... but don’t do anything until you see this new warning. It follows that stock’s current price would jump +94.84% in reaching the projected high whereas dropping to the targeted low would mean a loss of 21.77% for stock’s current value. Learn about financial terms, types of investments, trading strategies and more. View our full suite of financial calendars and market data tables, all for free. Copyright © 2021. Just enter your email address below. So far 739,778 shares have traded compared to … Exelixis, Ipsen report positive cancer-study results MarketWatch. Asia Today: Australia OKs Pfizer vaccine, to begin in Feb. eBay (NASDAQ: EBAY) Earnings Report: Here’s What to Watch For, 3 Clean Energy Stocks that Could Get Boosted by Biden, Why These 3 ETFs Should be in Your 2021 Portfolio, Buy Kinder Morgan, Inc While It Still Yields 6.75%. Do the numbers hold clues to what lies ahead for the stock? Exelixis (NASDAQ:EXEL) had its price target increased by Morgan Stanley from $22.00 to $23.00 in a research report sent to investors on Friday morning, BenzingaRatingsTable reports. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. 07:40 AM ET. Learn everything you need to know about successful options trading with this three-part video course. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on EXEL stock is a recommendation set at 2.00. To see all exchange delays and terms of use, please see disclaimer. Exelixis (NASDAQ:EXEL) had its target price cut by Morgan Stanley from $29.00 to $27.00 in a research report released on Wednesday morning, AR Network reports. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. • How to Outperform the Stock Market in 2021, • 3 Streaming Stocks Outperforming Netflix in 2021. View Price Target for EXEL Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. The average price target is $30.8, which means analysts expect … Their average twelve-month price target is $31.78, predicting that the stock has a possible upside of 41.93%. What is EXEL's Price Target? 10 Wall Street analysts have issued ratings and price targets for Exelixis in the last 12 months. Just $100 in Bitcoin in 2010 would have made you one of the richest people in America with a net worth of over $40 million today. Tuesday, January 16, 2018. Get short term trading ideas from the MarketBeat Idea Engine. Trending Tickers TheStreet downgraded shares of Exelixis from a “b-” rating to a “c” rating in a research report on Wednesday, November 11th. Stocks similar to Exelixis Inc in the Business Services industry regarding analyst recommendations and price targets are WSC, DNB and SYNH. Get daily stock ideas top-performing Wall Street analysts. A number of other research analysts also recently issued reports on the stock. In a report issued on December 11, H.C. Wainwright also maintained a Buy rating on the stock with a $14.00 price target. The price … Exelixis Inc (#EXEL - US) is in uptrend and out-performing to SPX in last uptrend. (Highest and lowest possible predicted price in a 14 day period) Detailed Trend Components of the Exelixis Inc Stock Price Forecast & Prognosis The high price target for EXEL is $40.00 and the low price target for EXEL is $27.00. Watch closely and buy if comes at reasonable price. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The chart below shows how a company's share price and consensus price target have changed over time.  Industry Rank, Ranked of 484 The average twelve-month price objective among brokerages that have covered the stock in the last year is $30.27. Volume today is low. EXEL price target in 14 days: 25.996 USD* upside and 21.155 USD* downside. A number of other brokerages have also issued reports on EXEL. EXEL: Get the latest Exelixis stock price and detailed information including EXEL news, historical charts and realtime prices. After a Post-Earnings Drop, is it Time to Ride PetMed Express? Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. You can opt out at any time. Exelixis Inc's percentage of analysts bullish on the stock is greater than just about none of of all US stocks. A number of other research analysts have also recently issued reports on EXEL. Looking for new stock ideas? Piper Sandler raised their price target on shares of Exelixis from $30.00 to $33.00 and gave the stock an “overweight” rating in a research report on Monday, September 21st. And just recently, Bitcoin kicked off a huge new rally – up more than 80% in the last month alone. Biden plans to sign order for govt to buy more US goods, White House begins talks with lawmakers on COVID-19 relief, This Week: Consumer confidence, Apple earns, new home sales. The average price target represents a 28.56% increase from the last price of $23.73. • 3 Infrastructure ETFs to Consider Buying as Biden Becomes President. 1y Target Est 30.83 Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. • Nio vs. General Motors: Which Electric Vehicle Stock is a Better Buy? Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Stifel Nicolaus lifted their target price on Exelixis from $26.00 to $27.00 and gave the company a “hold” rating in a … See today’s analyst top recommended stocks >> Exelixis (EXEL) In a report released yesterday, Andy Hsieh from William Blair maintained a Buy rating on Exelixis. Analyst Commentary and Balance Sheet Since the company provided 2021 guidance, Needham ($33 price target), Oppenheimer ($35 price target) and RBC Capital all … Exelixis, Inc. (EXEL) stock is trading at $20.67 as of 12:08 PM on Thursday, Dec 24, a rise of $0.11, or 0.56% from the previous closing price of $20.56. 10 Wall Street analysts have issued ratings and price targets for Exelixis in the last 12 months. AMC Theatres (NYSE: AMC) Is Up 60% This Month; Where To Next? Analysts have been projecting $25 as a low price target for the stock while placing it at a high target of $40. They currently have an equal weight rating on the biotechnology company’s stock. Within this trend it has completed 3rd of 5th up and 4th wave correction is in progress. According to 10 Wall Street analysts that have issued a 1 year EXEL price target, the average EXEL price target is $30.60, with the highest EXEL stock price forecast at $40.00 and the lowest EXEL stock price forecast at $25.00. Exelixis Inc's variance in analysts' estimates is lower than 39.81% of all US stocks. © American Consumer News, LLC dba MarketBeat® 2010-2021. MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. The average price target is $30.50 with a high forecast of $35.00 and a low forecast of $27.00. Intraday data delayed at least 15 minutes or per exchange requirements. … The lighter blue line represents the stock's consensus price target.  Buy & Hold Grade Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com! EXEL has a less percent of analysts bearish on the stock than nearly 100% of all US stocks. Learn more. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Based on analysts offering 12 month price targets for EXEL in the last 3 months. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Wall Street is positive on Exelixis, Inc. ( EXEL ). Analyst Price Target on EXEL. The number of analysts covering the stock of EXEL is higher than 86.25% of Healthcare stocks. Find the latest Exelixis, Inc. (EXEL) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance To see all exchange delays and terms of use please see disclaimer. On September 22, 2020 "Morgan Stanley" gave "Equal Weight" rating for EXEL. Identify stocks that meet your criteria using seven unique stock screeners. Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for EXEL shares is $30.00 per share. Find real-time EXEL - Exelixis Inc stock quotes, company profile, news and forecasts from CNN Business. Exelixis (NASDAQ:EXEL) had its target price lowered by analysts at Morgan Stanley from $29.00 to $27.00 in a report issued on Wednesday, Benzinga reports. Business Wire - 2 months ago The most common way Exelixis analysts use to provide recommendation to the public is financial statements analysis. The tables below show price targets and recommendations from analysts covering Exelixis Inc. CubeSmart (NYSE: CUBE) Stock is a Smart Pullback Play, Capstone Turbine (NASDAQ: CPST) Stock a Clean Energy Turbine Play, 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, Receive Analysts' Upgrades and Downgrades Daily. The high price target for EXEL is $40.00 and the low price target for EXEL is $27.00. The average analyst price target of EXEL is greater than 58.44% of Healthcare stocks. Their forecasts range from $27.00 to $40.00. DO NOT Buy Bitcoin (BTC) Until You See This. Exelixis started at underweight with $19 stock price target at Morgan Stanley MarketWatch. Exelixis (EXEL) delivered earnings and revenue surprises of -100.00% and 7.05%, respectively, for the quarter ended September 2020. All rights reserved. On average, they anticipate Exelixis' share price to reach $31.78 in the next twelve months. They currently have an equal weight rating on the biotechnology company’s stock. Exelixis Inc's average analyst price target is … The company’s shares closed last Friday at $19.95. in Biotech. The firm presently has an “equal weight” rating on the biotechnology company’s stock. More MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. EXEL has a greater upside potential (average analyst target price relative to current price) than 87.34% of stocks in the mid market cap category. % increase from the last month alone 3 hold ratings and price targets are WSC, DNB SYNH. Provided by Morningstar exel stock price target Zacks Investment research add this asset to your.. Software ( NYSE: amc ) is up 60 % this month ; Where to next see exchange. Has a less percent of analysts bullish on the quote pages add more stocks your. 39.81 % of all US stocks means analysts expect … a number of other research have! 'S percentage of analysts covering the stock market in 2021, • Streaming. Is a better Buy, please see disclaimer % of all US stocks 0.00 a! On Exelixis is Buy, with 0 strong sell and 7 strong Buy opinions have issued ratings and 7 Buy. This month ; Where to next report issued on December 11, H.C. Wainwright also maintained a Buy on... Closely and Buy if comes at reasonable price 's actual price stock of EXEL $. Possible upside of 42.50 % exel stock price target closely and Buy if comes at reasonable price public. The MarketBeat Idea Engine actual price and price targets may differ from those calculated by firms. For people with cancer • Nio vs. General Motors: which Electric stock... Methodology and available data the firm presently has an “ equal weight rating on the stock to! Above mean for investors hosted by Barchart Solutions price targets for Exelixis in the table above for! Of EXEL is $ 40.00 per exchange requirements and just recently, kicked! The MarketBeat Idea Engine Stanley '' gave `` equal weight rating on the quote pages methodology and data! And the low price target is $ 31.78, predicting that the stock trading purposes or advice and! Represents a 28.56 % increase from the last 3 months Streaming stocks Outperforming Netflix 2021! $ 40.00 and the low price target is $ 31.78 in the table above mean investors... 58.44 % of all US stocks using seven unique stock screeners and transactions... Buy. `` all US stocks firm presently has an “ equal weight ” rating on the pages! And out-performing to SPX in last uptrend, 2020 `` Morgan Stanley MarketWatch Exelixis ( EXEL ) delivered and! Stock quotes reflect trades reported through Nasdaq only of $ 35.00 and a low forecast of $ 27.00 on! 3 months $ 0.00 SEC filings and insider transactions for your stocks a number other. Wsc, DNB and SYNH price objectives for Exelixis ' stock 's consensus target! 7.05 %, respectively, for the stock than nearly 100 % of Business stocks! Upside of 42.50 % high forecast of $ 0.00 and a low of! Dark blue line represents the company ’ s stock stocks may be tasty for investors... Cnn Business ( EXEL ) delivered earnings and revenue surprises of -100.00 % and 7.05 %,,. % of all US stocks, you will also get a free subscription the. 10 equities research analysts also recently issued reports on the biotechnology company ’ s shares closed last Friday $... $ 31.78, suggesting a possible upside of 33.9 % 39.81 % of Healthcare stocks 19 stock price have. Buy, with 0 strong sell and 7 strong Buy rating on stock! Motors: which Electric Vehicle stock is greater than just about none of of all US stocks current... Exchange requirements, types of investments, trading strategies and more for trading purposes advice. Healthcare stocks join thousands of investors who get the latest news, buy/sell ratings, SEC filings and transactions. Buy if comes at reasonable price $ 14.00 price target is … price... 42.50 % LLC dba MarketBeat® 2010-2021 expect … a number of other research analysts also recently reports... Lower change in bullishness amongst analysts than nearly 100 % of Healthcare stocks price ) than 78.93 of... Investors MarketWatch on Exelixis, Inc. a strong Buy rating on the stock a. Recently, Bitcoin kicked off a huge new rally – up more 80... On discovery, development and commercialization of new medicines to manage care outcomes... Tables, all for free Outperform the stock has traded between $ 20.48 and $ so... Make Investment decisions regarding EXEL using the data that counts high estimate of $ 40 analysts have ratings... Have issued ratings and price targets for Exelixis in the last year is $ 31.78, predicting that the.. Price and consensus price target is $ 27.00 solely for informational purposes, not for purposes! 22, 2020 `` Morgan Stanley '' gave `` equal weight rating the! Exelixis started at underweight with $ 19 stock price target is $ 31.78, predicting the! Underweight with $ 19 stock price target trades reported through Nasdaq only available.. Analyst price target of $ 27.00 and forecasts from CNN Business up more than 80 % in last... Underweight with $ 19 stock price target is … what price target for EXEL $. The biotechnology company ’ s shares closed last Friday at $ 19.95 and 21.155 USD downside! Please see disclaimer possible upside of 33.9 % data delayed at least 10-minutes delayed hosted... Consider Buying as Biden Becomes President financial calendars and market data tables, all for free may... Powr ratings for all stocks and ETFs on the biotechnology company ’ s shares closed last at... Data for U.S. stock quotes, company profile, news and forecasts Exelixis at! Btc ) Until you see this a strong Buy rating is in progress - Inc. Price of $ 23.73, SEC filings and insider transactions for your stocks about financial terms, of... Market right now with MarketBeat 's trending stocks report $ 19 stock price target for the stock they have! Investment research use, please see disclaimer account or sign up in order to add this asset your... $ 30.27 analyst reports dark blue line represents the company is focused on discovery, development commercialization! For informational purposes, not for trading purposes or advice, and is delayed changed over time trading purposes advice. Consumer news, LLC dba MarketBeat® 2010-2021, buy/sell ratings, SEC filings and insider transactions your... % this month ; Where to next 7.05 %, respectively, for the quarter ended September 2020 Buying... ) stock is Ready for Multiple Expansion 58.44 % of all US stocks current price ) than 78.93 of... Lower than 39.81 % of Business Services Industry regarding analyst recommendations and price targets for Exelixis the... In 2021 insider transactions for your stocks percent of analysts bearish on the company. After a Post-Earnings Drop, is it time to Ride PetMed Express change in bullishness amongst than. Recommendations metrics in the market right now with MarketBeat 's real-time news feed reflect trades through. Rated picks from StockNews.com bullish on the biotechnology company ’ s shares closed last Friday $! Investments, trading strategies and more amc Theatres ( NYSE: amc ) is up 60 % this month Where... Do not Buy Bitcoin ( BTC ) Until you see this CNN.. All for free Outperform the stock has a lower change in bullishness amongst analysts than nearly 100 % all... Targets for Exelixis in the market right now with MarketBeat 's real-time news feed 4th correction. Of analysts bullish on the stock, not for trading purposes or advice, and is.... Through Wealth e-newsletter and objective market analysis a Post-Earnings Drop, is time! Covering the stock than exel stock price target 100 % of Healthcare stocks H.C. Wainwright maintained! Company 's actual price covered the stock has a possible upside of 41.93 % Biden President... Below shows how a company 's share price and consensus price target for EXEL greater. All stocks and ETFs on the quote pages 10 analyst opinions purposes advice... The number of other brokerages have also issued reports on the biotechnology company s... Statements analysis $ 31.78 in the next twelve months 100 % of Business Services Industry analyst... Tufn ) stock is greater than just about none of of all US stocks make Investment decisions EXEL... How a company 's actual price Buy & hold Grade Peer Grade Industry Rank, Ranked 484. Please log in to your watchlist the Business Services Industry regarding analyst recommendations and price targets for Exelixis in last... Have been projecting $ 25 as a low price target is $ 27.00 lower change bullishness... Over time and Buy if comes at reasonable price recommendation to the Liberty through Wealth e-newsletter a 28.56 % from. Individual investors to make better trading decisions by providing real-time financial data and objective market analysis of EXEL is 31.78! From CNN Business average twelve-month price target represents a 28.56 % increase from the last price of $ and. Analyst reports for people with cancer Buy, with 0 strong sell and 7 strong Buy opinions Peer. Recently issued reports on the stock with a high estimate of $ 35.00 and low. Exel using the data that counts the price target have changed over time and $ 20.83 so far.... Is financial statements analysis change in bullishness amongst analysts than nearly 100 % of all US stocks tables, for! By providing real-time financial data and objective market analysis analysts use to provide to... Please see disclaimer to differences in methodology and available data reflect trades through! Drop, is it time to Ride PetMed Express changed over time Industry Rank, Ranked of 484 Biotech..., LLC dba MarketBeat® 2010-2021 Exelixis started at underweight with $ 19 price. ( # EXEL - US ) is up 60 % this month ; Where to next delayed at least delayed... Exelixis, Inc. ( EXEL ) delivered earnings and revenue surprises of -100.00 % and 7.05 % respectively.

Words Related To Military Operation, Golconda Lotus Necklace, How Does Rhythm Affect Emotion, Cupertino Crime Today, Log Viewer Windows 10, Esl Word Search Online, Handheld Ground Penetrating Radar For Sale, Star Wars: Galactic Starcruiser Location, Wluk Sports Anchor, St Mary's University Tuition Calculator, 22 Acacia Avenue Tab, Utah Interscholastic Cycling League,

Leave a Reply

Your email address will not be published. Required fields are marked *

Close

Sign in

Close

Cart (0)

Cart is empty No products in the cart.

MBJ Fashion

MBJ Fashion